Some antidepressants take weeks to kick in, and scientists may now know why

by Cara MurezMost folks know that certain antidepressants have to be taken for a few weeks before people start seeing improvement, and now a new study sheds light on that delay.Scientists have discove

Updated on: January 11,2024

Some antidepressants take weeks to kick in, and scientists may now know why

by Cara MurezMost folks know that certain antidepressants have to be taken for a few weeks before people start seeing improvement, and now a new study sheds light on that delay.Scientists have discove

Updated on:January 11,2024

MS treatment that 'resets' immune system may halt disease progression for at least five years

by Imperial College LondonDemyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit:CC BY-SA 3.0Marvin 101/Wikiped

Updated on: April 01,2024

MS treatment that 'resets' immune system may halt disease progression for at least five years

by Imperial College LondonDemyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit:CC BY-SA 3.0Marvin 101/Wikiped

Updated on:April 01,2024

Sleep and stress give clues to understanding epileptic seizures

byUniversity of BirminghamCredit: Unsplash/CC0 Public DomainSleeping patterns and stress hormones could be the key to understanding how and when people with epilepsy are likely to experience sei

Updated on: January 11,2024

Sleep and stress give clues to understanding epileptic seizures

byUniversity of BirminghamCredit: Unsplash/CC0 Public DomainSleeping patterns and stress hormones could be the key to understanding how and when people with epilepsy are likely to experience sei

Updated on:January 11,2024

The ego-consciousness of roosters evaluated in mirror test

by Johannes Seiler, Rheinische Friedrich-Wilhelms-Universität BonnBielefelder rooster with mark. The pink mark in the "triangle-region" between the wattles was applied with colored starch po

Updated on: January 12,2024

The ego-consciousness of roosters evaluated in mirror test

by Johannes Seiler, Rheinische Friedrich-Wilhelms-Universität BonnBielefelder rooster with mark. The pink mark in the "triangle-region" between the wattles was applied with colored starch po

Updated on:January 12,2024

Exploring the brain basis of concepts by using a new type of neural network

by Japhet Johnstone,Free University of BerlinSchematic illustration of constraints for making neural networks more similar to real brains. Credit:Progress in Neurobiology(2023). DOI:

Updated on: January 12,2024

Exploring the brain basis of concepts by using a new type of neural network

by Japhet Johnstone,Free University of BerlinSchematic illustration of constraints for making neural networks more similar to real brains. Credit:Progress in Neurobiology(2023). DOI:

Updated on:January 12,2024

Researchers highlight benefits of sharing human brain data

by Graciela Gutierrez,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainIn recent years, the scientific community has seen a push for more findable, accessible, interoperable, and reus

Updated on: January 10,2024

Researchers highlight benefits of sharing human brain data

by Graciela Gutierrez,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainIn recent years, the scientific community has seen a push for more findable, accessible, interoperable, and reus

Updated on:January 10,2024

Unlikely that high cholesterol or statins increase the risk of dementia

by Cecilie Bakken Høstmark,University of OsloIn professor Kjetil Retterstøl's new study, he found that neither high cholesterol itself nor statins can explain an increased risk of developing

Updated on: June 04,2024

Unlikely that high cholesterol or statins increase the risk of dementia

by Cecilie Bakken Høstmark,University of OsloIn professor Kjetil Retterstøl's new study, he found that neither high cholesterol itself nor statins can explain an increased risk of developing

Updated on:June 04,2024

Combination drug therapy shows promise for a treatment-resistant cancer

by Johns Hopkins University School of MedicineChristine Pratilas, M.D., in the lab. Credit: Frederick W. Dubs, Johns Hopkins Pathology Photography & GraphicsA combination of two cancer drugs

Updated on: May 21,2024

Combination drug therapy shows promise for a treatment-resistant cancer

by Johns Hopkins University School of MedicineChristine Pratilas, M.D., in the lab. Credit: Frederick W. Dubs, Johns Hopkins Pathology Photography & GraphicsA combination of two cancer drugs

Updated on:May 21,2024

Study: Gut health plays a role in Alzheimer's development

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainA series of experiments presented today at the Alzheimer's Research UK 2022 Conference at the Brighton Centre, has implicated th

Updated on: April 20,2024

Study: Gut health plays a role in Alzheimer's development

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainA series of experiments presented today at the Alzheimer's Research UK 2022 Conference at the Brighton Centre, has implicated th

Updated on:April 20,2024

Studies of migraine’s many triggers offer paths to new therapies

Updated on: October 21,2024

Studies of migraine’s many triggers offer paths to new therapies

Updated on:October 21,2024

Mature 'lab grown' neurons hold promise for neurodegenerative disease

by Northwestern UniversityFluorescent images of human neurons (stained with red, green and blue) growing on coatings with fast-moving molecules (left) or conventional laminin (right) for 72 hours

Updated on: February 05,2024

Mature 'lab grown' neurons hold promise for neurodegenerative disease

by Northwestern UniversityFluorescent images of human neurons (stained with red, green and blue) growing on coatings with fast-moving molecules (left) or conventional laminin (right) for 72 hours

Updated on:February 05,2024

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Updated on: February 24,2024

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Updated on:February 24,2024